Matrix M adjuvant

Search documents
Novavax (NVAX) FY Conference Transcript
2025-06-11 19:00
Novavax (NVAX) FY Conference June 11, 2025 02:00 PM ET Speaker0 Are we ready to go? Are we live? Oh, hello, everyone. Speaker1 Hi, I'm John Jacobs, CEO of Novavax, and I'm joined here today by Jim Kelly, our CFO, and Doctor. Roxandra Draghia, who heads up our R and D. I want to thank everyone who's here today to join us and listening in to our presentation at the Goldman Sachs forty sixth Annual Global Healthcare Conference. Today's 06/11/2025. I'll advance the slide to our cautionary note regarding forward ...
Novavax(NVAX) - 2025 Q1 - Earnings Call Transcript
2025-05-08 13:32
Novavax (NVAX) Q1 2025 Earnings Call May 08, 2025 08:30 AM ET Company Participants Luis Sanay - Vice President of Investor RelationJohn Jacobs - President & CEORuxandra Draghia-Akli - Executive Vice President, Head of Research & DevelopmentJim Kelly - Executive Vice President, Chief Financial Officer and TreasurerMayank Mamtani - Senior Managing DirectorJohn Trizzino - President & COO Conference Call Participants Roger Song - Senior Equity Research AnalystAlec Stranahan - AnalystThomas Shrader - Equity Rese ...
Novavax(NVAX) - 2025 Q1 - Earnings Call Transcript
2025-05-08 13:30
Novavax (NVAX) Q1 2025 Earnings Call May 08, 2025 08:30 AM ET Speaker0 Good morning, and welcome to Novavax First Quarter twenty twenty five Financial Results and Operational Highlights Conference Call. All participants will be in a listen only mode. After today's presentation, there will be an opportunity to ask questions. Please note, this event is being recorded. I'd now like to turn the conference over to Luis Sannai, Vice President, Investor Relations. Please go ahead. Speaker1 Good morning, and thank ...